High Dose Consensus Interferon in Nonresponders to Interferon Alpha-2B and Ribavirin with Chronic Hepatitis C
OBJECTIVES: Approximately 60% of patients with chronic hepatitis C treated with a combination of interferon (IFN) alpha-2b and ribavirin are nonresponders. The purpose of the present study was to evaluate the efficacy of treatment with high dose consensus IFN (CIFN) (15 µg/day) in nonresponders.
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2003-01-01
|
| Series: | Canadian Journal of Gastroenterology |
| Online Access: | http://dx.doi.org/10.1155/2003/131943 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832547463479689216 |
|---|---|
| author | David N Moskovitz Pooma Manoharan E Jenny Heathcote |
| author_facet | David N Moskovitz Pooma Manoharan E Jenny Heathcote |
| author_sort | David N Moskovitz |
| collection | DOAJ |
| description | OBJECTIVES: Approximately 60% of patients with chronic hepatitis C treated with a combination of interferon (IFN) alpha-2b and ribavirin are nonresponders. The purpose of the present study was to evaluate the efficacy of treatment with high dose consensus IFN (CIFN) (15 µg/day) in nonresponders. |
| format | Article |
| id | doaj-art-c9a81bc680fe49a993b52f5aa17b3cfa |
| institution | Kabale University |
| issn | 0835-7900 |
| language | English |
| publishDate | 2003-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | Canadian Journal of Gastroenterology |
| spelling | doaj-art-c9a81bc680fe49a993b52f5aa17b3cfa2025-02-03T06:44:47ZengWileyCanadian Journal of Gastroenterology0835-79002003-01-0117847948210.1155/2003/131943High Dose Consensus Interferon in Nonresponders to Interferon Alpha-2B and Ribavirin with Chronic Hepatitis CDavid N Moskovitz0Pooma Manoharan1E Jenny Heathcote2Department of Medicine, University of Toronto, Toronto, Ontario, CanadaDepartment of Medicine, University of Toronto, Toronto, Ontario, CanadaDepartment of Medicine, University of Toronto, Toronto, Ontario, CanadaOBJECTIVES: Approximately 60% of patients with chronic hepatitis C treated with a combination of interferon (IFN) alpha-2b and ribavirin are nonresponders. The purpose of the present study was to evaluate the efficacy of treatment with high dose consensus IFN (CIFN) (15 µg/day) in nonresponders.http://dx.doi.org/10.1155/2003/131943 |
| spellingShingle | David N Moskovitz Pooma Manoharan E Jenny Heathcote High Dose Consensus Interferon in Nonresponders to Interferon Alpha-2B and Ribavirin with Chronic Hepatitis C Canadian Journal of Gastroenterology |
| title | High Dose Consensus Interferon in Nonresponders to Interferon Alpha-2B and Ribavirin with Chronic Hepatitis C |
| title_full | High Dose Consensus Interferon in Nonresponders to Interferon Alpha-2B and Ribavirin with Chronic Hepatitis C |
| title_fullStr | High Dose Consensus Interferon in Nonresponders to Interferon Alpha-2B and Ribavirin with Chronic Hepatitis C |
| title_full_unstemmed | High Dose Consensus Interferon in Nonresponders to Interferon Alpha-2B and Ribavirin with Chronic Hepatitis C |
| title_short | High Dose Consensus Interferon in Nonresponders to Interferon Alpha-2B and Ribavirin with Chronic Hepatitis C |
| title_sort | high dose consensus interferon in nonresponders to interferon alpha 2b and ribavirin with chronic hepatitis c |
| url | http://dx.doi.org/10.1155/2003/131943 |
| work_keys_str_mv | AT davidnmoskovitz highdoseconsensusinterferoninnonresponderstointerferonalpha2bandribavirinwithchronichepatitisc AT poomamanoharan highdoseconsensusinterferoninnonresponderstointerferonalpha2bandribavirinwithchronichepatitisc AT ejennyheathcote highdoseconsensusinterferoninnonresponderstointerferonalpha2bandribavirinwithchronichepatitisc |